COMT and chronic hepatitis C virus infection: The variant is associated with the efficacy in response to peginterferon alfa-2b in patients suffering from chronic hepatitis C. A missense variant in COMT gene (Val158Met, rs4680, PharmGKB 2A) reached the MAFSlo of 48.6%, which is in line with gnomAD MAF frequency of 46.3%.